🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Ken Fisher’s Top 30 Long Positions, Q3/2012

Published 12/25/2012, 04:12 AM
Updated 07/09/2023, 06:31 AM
TTEF
-
BHP
-
GSK
-
PFE
-
IBM
-
GE
-

Kenneth Fisher is an American businessman, founder and chairman as well as CEO of Fisher Investments, a money management firm headquartered in California. Fisher writes the monthly “Portfolio Strategy” column in Forbes magazine. Ken Fisher is one of the richest Americans and part of the Forbes 400 list of world billionaires. Funds run by Ken Fisher at Fisher Asset Management were valued at USD 34.91 billion.

Here is a list of his top 30 investment positions as of September 30, 2012. During the quarter Q3/2012, Ken Fisher had 458 total positions.

Top New Buys: CMCSA, PBR, TM, RY, NVS, VOD, CHL, NTGR, SAM, WRC

GlaxoSmithKline (GSK) has a market capitalization of $107.56 billion. The company employs 97,389 people, generates revenue of $44.150 billion and has a net income of $8.798 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $14.844 billion. The EBITDA margin is 33.62 percent (the operating margin is 28.50 percent and the net profit margin 19.93 percent).

Financial Analysis: The total debt represents 36.27 percent of the company’s assets and the total debt in relation to the equity amounts to 185.52 percent. Due to the financial situation, a return on equity of 62.19 percent was realized. Twelve trailing months earnings per share reached a value of $3.20. Last fiscal year, the company paid $2.26 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 13.66, the P/S ratio is 2.42 and the P/B ratio is finally 8.48. The dividend yield amounts to 5.31 percent and the beta ratio has a value of 0.65.

Long-Term Stock History Chart Of GlaxoSmithKline

Long-Term Dividends History of GlaxoSmithKline

Long-Term Dividend Yield History of GlaxoSmithKline
Pfizer (PFE) has a market capitalization of $184.65 billion. The company employs 103,700 people, generates revenue of $67.425 billion and has a net income of $8.739 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $23.011 billion. The EBITDA margin is 34.13 percent (the operating margin is 18.93 percent and the net profit margin 12.96 percent).

Financial Analysis: The total debt represents 20.72 percent of the company’s assets and the total debt in relation to the equity amounts to 47.39 percent. Due to the financial situation, a return on equity of 10.24 percent was realized. Twelve trailing months earnings per share reached a value of $1.25. Last fiscal year, the company paid $0.80 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 20.03, the P/S ratio is 2.74 and the P/B ratio is finally 2.31. The dividend yield amounts to 3.83 percent and the beta ratio has a value of 0.70.

Long-Term Stock History Chart Of Pfizer

Long-Term Dividends History of Pfizer

Long-Term Dividend Yield History of Pfizer
General Electric (GE) has a market capitalization of $218.32 billion. The company employs 301,000 people, generates revenue of $147.300 billion and has a net income of $14.366 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $31.015 billion. The EBITDA margin is 21.06 percent (the operating margin is 13.64 percent and the net profit margin 9.75 percent).

Financial Analysis: The total debt represents 63.22 percent of the company’s assets and the total debt in relation to the equity amounts to 389.43 percent. Due to the financial situation, a return on equity of 11.06 percent was realized. Twelve trailing months earnings per share reached a value of $1.35. Last fiscal year, the company paid $0.61 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 15.45, the P/S ratio is 1.48 and the P/B ratio is finally 1.89. The dividend yield amounts to 3.65 percent and the beta ratio has a value of 1.61.

Long-Term Stock History Chart Of General Electric

Long-Term Dividends History of General Electric

Long-Term Dividend Yield History of General Electric
Take a closer look at all top portfolio positions of Ken Fisher. The average P/E ratio amounts to 19.09. The dividend yield has a value of 2.71 percent. Price to book ratio is 4.03 and price to sales ratio 3.18.

Here are Ken Fisher’s Top 30 Long Positions:

Top 30 Positions Of Ken Fisher Fund Portfolio Q3-2012

Ticker Company
Related stock ticker symbols:
LQD, PFE, JNJ, CSCO, GE, IBM, AXP, V, AMZN, WFC, AAPL, ORCL, NSRGY, SNY, HBC, PEP,
SLB, QCOM, GSK, JPM, GOOG, MSFT, TSM, MCD, RIO, PG, HD, PM, BHP

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.